Martina Porter - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Why Lockheed Martin’s $101.6 m Army award matters more than its size suggests for LMT stock

Representative image of targeted protein degradation research as SK Life Science Labs presents new preclinical p300 and PRMT5 cancer data at AACR 2026.

Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight

Why Cerebras’ IPO filing looks less like a chip listing and more like an AI infrastructure wager

What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence

Representative image of oral hidradenitis suppurativa treatment research as Incyte Corporation reports positive 54-week povorcitinib Phase 3 data, highlighting the race to expand HS therapy options.

Read More

Pharma Industry News

Incyte (NASDAQ: INCY) moves closer to an hidradenitis suppurativa launch as 54-week povorcitinib data hold up

Incyte Corporation’s new 54-week povorcitinib data could reshape hidradenitis suppurativa treatment. Read what it means for INCY now.

byPallavi Madhiraju

March 29, 2026

web analytics